Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

Malik S., Hassan S., EŞKAZAN A. E.

EXPERT REVIEW OF HEMATOLOGY, cilt.14, sa.11, ss.975-978, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 14 Sayı: 11
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/17474086.2021.1990034
  • Dergi Adı: EXPERT REVIEW OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.975-978
  • Anahtar Kelimeler: Asciminib, chronic myeloid leukemia, flumatinib, HQP1351, K0706, novel therapies, olverembatinib, PF-114, tyrosine kinase inhibitor, vodobatinib, ASCIMINIB, THERAPY
  • İstanbul Üniversitesi Adresli: Hayır